COSMOS Pharmaceutical Overhauls Organization, Launches Legal and Hotel Departments

The latest announcement is out from COSMOS Pharmaceutical Corporation ( (JP:3349) ).

COSMOS Pharmaceutical Corporation has announced a series of organizational and personnel changes effective February 1, 2026, aimed at strengthening governance and diversifying its business. The company will establish a new Legal Affairs Department to reinforce its internal structure and launch a Hotel Department, signaling a clearer commitment to hotel-related operations, while dissolving the Product Development Department and integrating its functions into the Products Department as a dedicated Product Development Section. Alongside these structural shifts, several key executives will assume new roles, including Director Futoshi Shibata becoming Director and Manager of the newly created Legal Affairs Department and Yukitaka Uno moving to lead the new Hotel Department, reshaping the leadership lineup across planning, finance, products, store development, and hotel divisions to better align with the revised organization.

The most recent analyst rating on (JP:3349) stock is a Buy with a Yen9500.00 price target. To see the full list of analyst forecasts on COSMOS Pharmaceutical Corporation stock, see the JP:3349 Stock Forecast page.

More about COSMOS Pharmaceutical Corporation

COSMOS Pharmaceutical Corporation, listed on the TSE Prime Market under securities code 3349, operates in the pharmaceutical and healthcare retail industry, providing drugstore and related services and expanding into ancillary businesses such as hotel operations. The company is led by President Hideaki Yokoyama and continues to refine its internal structure to support growth and operational efficiency.

Average Trading Volume: 488,833

Technical Sentiment Signal: Buy

Current Market Cap: Yen608.3B

For a thorough assessment of 3349 stock, go to TipRanks’ Stock Analysis page.